(Q39940743)

15 September 2017

Excess mortality and cause of death in a cohort of Norwegian multiple sclerosis patients (English)

1 reference

Elisabeth Gulowsen Celius

15 September 2017

0 references

1 reference

series ordinal

3

object named as

E G Celius

1 reference

15 September 2017

C Smestad

1

1 reference

PubMed ID

19812114

15 September 2017

L Sandvik

series ordinal

2

1 reference

15 September 2017

7 October 2009

1 reference

Multiple Sclerosis Journal

15 September 2017

1 reference

15 September 2017

15

1 reference

15 September 2017

11

1 reference

15 September 2017

1263-1270

1 reference

Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland

15 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F1352458509107010

Epidemiology of multiple sclerosis in US veterans. VIII. Long-term survival after onset of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509107010

Trends in survival and cause of death in Danish patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509107010

Survival and cause of death in multiple sclerosis: a prospective population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509107010

Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509107010

Long-term survival of patients with multiple sclerosis in West France.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509107010

Underlying cause of death in Danish patients with multiple sclerosis: results from the Danish Multiple Sclerosis Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509107010

Underlying cause of death as recorded for multiple sclerosis patients: associated factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509107010

Multiple sclerosis in Oslo, Norway: prevalence on 1 January 1995 and incidence over a 25-year period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509107010

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509107010

Defining the clinical course of multiple sclerosis: Results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509107010

Cause of death in patients attending multiple sclerosis clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509107010

Survival of multiple sclerosis in Finland between 1964 and 1993.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509107010

Suicide among Danes with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509107010

Prognostic factors for survival in multiple sclerosis: a longitudinal, population based study in Møre and Romsdal, Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509107010

21 January 2018

Identifiers

DOI

10.1177/1352458509107010

1 reference

15 September 2017

1 reference

PubMed ID

19812114